Preserving What Matters: How Institutional Knowledge Protects Value Through M&A

An acquisition can accelerate a clinical program—or unintentionally slow it down if critical knowledge is lost along the way.

During M&A transitions, sponsors inherit more than assets and pipelines; they inherit years of scientific decisions, regulatory interactions, operational lessons, and analytical rationale that shape a program’s future success. While documentation captures what happened, institutional knowledge explains why it happened, and that context is essential. This article explores how experienced CRO partners help bridge ownership changes by safeguarding program history, supporting seamless knowledge transfer, and guiding organizations through complex post-acquisition decisions. From regulatory strategy and data interpretation to clinical operations and evidence generation, continuity can reduce risk and accelerate progress when timelines and stakes are highest.

For sponsors navigating an acquisition, protecting institutional knowledge is a competitive advantage. Discover how the right partnerships can help preserve momentum, minimize disruption, and position your program for long-term success.